In normal cells, this full length EpCAM protein is sequestered in tight junctions and therefore less accessible to antibodies, whereas in cancer cells it is homogeneously distributed on the cancer cell surface and has been explored as a surface-binding site for therapeutic antibodies. The gene discussed is EPCAM; the disease is cancer.